Farmak JSC increased its medicine sales by 18.35%
Farmak JSC increased sales of medicines by 18.35%
According to the results of Q1 2018, Farmak JSC increased its sales by 18.35% to 1.1 billion UAH against Q1 2017. Proxima Research data.
“For eight years straight now Farmak has been the leader on the pharmaceutical market of the country*. The company has achieved such results due to quality and innovation. Over the past seven years Farmak has spent 2.8 billion hryvnyas on the development and modernization of production. Today, all the equipment of the Company is high-tech and ultra-modern. Production lines meet GMP, ISO requirements. Farmak’s focus is the manufacture of innovative biotech products. These include Flenox, insulin and its analogues, X-ray contrast agents. At the same time, we continue to produce basic drugs that have been on the market for a few decades,” said Volodymyr Kostiuk, acting Executive Director of Farmak JSC.
Farmak was granted a finalist award by the UN Global Compact Network for the Eco-School project The Partnership for Sustainability Award 2019 is an international competition of partnership projects held among different organizations to achieve sustainable development goals, which is initiated by the UN Global Compact Local Network in Ukraine. Eco-School by F...
According to the results of the 20th contest of professionals in the pharmaceutical industry of Ukraine “Panacea”. Farmak was announced as a winner nominated as “The Company of the Year” during the awards ceremony of the 20th competition of professionals in the pharmaceutical industry of Ukraine “Panacea 2019” which was held on September 18. “The […]
The Company was awarded for the projects aimed at raising the environmental awareness of the society and implementing the latest technologies and innovative approaches. The major projects are: “Eco-School”, “Farmak: Run For Your Health”, etc. The purpose of the Eco-School project is to unite and create a community of young environmental activists, promote en...